Sfoglia per AUTORE
RADIN M
Collezione ASL Città di Torino

  

Items : 36

Diagnostic, research, and real-life effect of the 2023 EULAR-ACR classification criteria for antiphospholipid syndrome. in The Lancet. Rheumatology / Lancet Rheumatol. 2025 Mar 7:S2665-9913(24)00396-5. doi: 10.1016/S2665-9913(24)00396-5.
2025
ASL Città di Torino

Schreiber K; Aguilera S; Amengual O; Cohen H; Castro Oliveira De Andrade D; Duarte-García A; Gerosa M; Nelson-Piercy C; Radin M; Raio L; Sciascia S;

Biological therapies in thrombocytopenia and primary antiphospholipid syndrome: where are we now? in Expert opinion on biological therapy / Expert Opin Biol Ther. 2025 Mar 28. doi: 10.1080/14712598.2025.2484844.
2025
ASL Città di Torino

Radin M; Barinotti A; Galarza D; Cecchi I; Camerlo S; Vaccarino A; Roccatello D; Morotti A; Sciascia S;

Is it time for treat-to-target in antiphospholipid syndrome? in Autoimmunity reviews / Autoimmun Rev. 2025 Jan 3;24(1):103690. doi: 10.1016/j.autrev.2024.103690. Epub 2024 Nov 19.
2025
ASL Città di Torino

Sciascia S; Barilaro G; Radin M; Cervera R; Roccatello D;

2025
ASL Città di Torino

Ahmadzadeh Y; Magder LS; de Andrade DCO; Paredes-Ruiz D; Tektonidou MG; Pengo V; Sciascia S; Andreoli L; Signorelli F; Fortin PR; Efthymiou M; Belmont HM; Barilaro G; Clarke AE; Atsumi T; López-Pedrera C; Knight JS; Branch DW; Willis R; Kello N; Zhang Z; Almaraz ER; Artim-Esen B; Pardos-Gea J; Pons-Estel G; Pazzola G; Shi H; Duarte-García A; Thaler J; et alii...

2024
ASL Città di Torino

Sciascia S; Ferrara G; Roccatello L; Rubini E; Foddai SG; Radin M; Cecchi I; Rossi D; Barinotti A; Ricceri F; Gilcrease W; Baldovino S; Ferreira Poshar A; Conti A; Fenoglio R;

Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2024 Mar;50(2):182-187. doi: 10.1055/s-0043-1764472. Epub 2023 Mar 20.
2024
ASL Città di Torino

Radin M; Cecchi I; Arbrile M; Montin D; Farinasso L; Cioffi M; Foddai SG; Barinotti A; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.
2023
ASL Città di Torino

Sciascia S; Rilat MLA; Fenoglio R; Foddai SG; Radin M; Cecchi I; Cinnirella G; Crosasso P; Guidetti MG; Barinotti A; Baldovino S; Menegatti E; Roccatello D;

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D; Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D;

Health inequalities and social determinants of health: The role of syndemics in rheumatic diseases. in Autoimmunity reviews / Autoimmun Rev. 2023 Jul;22(7):103351. doi: 10.1016/j.autrev.2023.103351. Epub 2023 Apr 28.
2023
ASL Città di Torino

Gilcrease GW; Sciascia S; Padovan D; Sciullo A; Cioffi M; Ricceri F; Radin M; Schreiber K; Husum D; Roccatello D; Nikiphorou E;

Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.
2023
ASL Città di Torino

Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D; Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D;

The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms? in Autoimmunity reviews / Autoimmun Rev. 2023 Feb;22(2):103237. doi: 10.1016/j.autrev.2022.103237. Epub 2022 Nov 19.
2023
ASL Città di Torino

Sciascia S; Arbrile M; Trunfio M; Calcagno A; Radin M; Roccatello D; Lembo D; Civra A;

16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends. in Lupus / Lupus. 2023 Dec;32(14):1625-1636. doi: 10.1177/09612033231211820. Epub 2023 Nov 7.
2023
ASL Città di Torino

Atsumi T; Chighizola CB; Fujieda Y; Mackie I; Radin M; Roubey R; Bertolaccini ML;

2022
ASL Città di Torino

Sciascia S; Foddai SG; Alessandri C; Alunno A; Andreoli L; Barinotti A; Calligaro A; Canti V; Carubbi F; Cecchi I; Chighizola CB; Conti F; Emmi G; Fioravanti A; Fischetti F; Franceschini F; Gerosa M; Hoxha A; Larosa M; Lazzaroni MG; Nalli C; Pazzola G; Radin M; Raffeiner B; Ramoni VL; Rubini E; Sebastiani GD; Truglia S; Urban ML; et alii...

Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):e1. doi: 10.1055/s-0043-1769787. Epub 2023 May 24.
2022
ASL Città di Torino

Sciascia S; Foddai SG; Alessandri C; Alunno A; Andreoli L; Barinotti A; Calligaro A; Canti V; Carubbi F; Cecchi I; Chighizola CB; Conti F; Emmi G; Fioravanti A; Fischetti F; Franceschini F; Gerosa M; Hoxha A; Larosa M; Lazzaroni MG; Nalli C; Pazzola G; Radin M; Raffeiner B; Ramoni VL; Rubini E; Sebastiani GD; Truglia S; Urban ML; et alii...

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.
2022
ASL Città di Torino

Foddai SG; Cecchi I; Rubini E; Radin M; Barinotti A; Rossi D; Sciascia S; Roccatello D;

Differentiating between UCTD and early-stage SLE: from definitions to clinical approach. in Nature reviews. Rheumatology / Nat Rev Rheumatol. 2022 Jan;18(1):9-21. doi: 10.1038/s41584-021-00710-2. Epub 2021 Nov 11.
2022
ASL Città di Torino

Mosca M; Pons-Estel G; Yazdany J; Parodis I; Radin M; Roccatello D; Sciascia S;

Quality of life measures in Systemic Lupus Erythematosus: A systematic review. in Reumatismo / Reumatismo. 2022 Feb 7;73(4). doi: 10.4081/reumatismo.2021.1447.
2022
ASL Città di Torino

Radin M; El Hasbani G; Barinotti A; Roccatello D; Uthman I; Taher A; Sciascia S;

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.
2022
ASL Città di Torino

Radin M; Arbrile M; Cecchi I; Di Nunzio P; Buccarano N; Di Gregorio F; Milone V; Osella S; Crosasso P; Favuzzi MD; Barinotti A; Baldovino S; Menegatti E; Rossi D; Sciascia S; Roccatello D;

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2022 Sep 12;13:957201. doi: 10.3389/fimmu.2022.957201. eCollection 2022.
2022
ASL Città di Torino

Naranjo L; Stojanovich L; Djokovic A; Andreoli L; Tincani A; Ma?li?ska M; Sciascia S; Infantino M; Garcinuño S; Kostyra-Grabczak K; Manfredi M; Regola F; Stanisavljevic N; Milanovic M; Saponjski J; Roccatello D; Cecchi I; Radin M; Benucci M; Pleguezuelo D; Serrano M; Shoenfeld Y; Serrano A;

Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study). in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):938-946. doi: 10.55563/clinexprheumatol/2b73dn. Epub 2020 Sep
2021
ASL Città di Torino

Chighizola CB; Crisafulli F; Hoxha A; Carubbi F; Bellan M; Monti S; Costa L; Baldi C; Radin M; Praino E; Coletto LA; Pregnolato F; Sciascia S; Sainaghi PP; Bellis E; Ramoni V; Quartuccio L; Alunno A; Gerosa M; Andreoli L;

The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1071-1076. doi: 10.55563/clinexprheumatol/c96ief. Epub 2020 N
2021
ASL Città di Torino

Schreiber K; Radin M; Cecchi I; Rubini E; Roccatello D; Jacobsen S; Cuadrado MJ; Sciascia S;

Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS). in European journal of internal medicine / Eur J Intern Med. 2021 Oct;92:134-136. doi: 10.1016/j.ejim.2021.07.004. Epub 2021 Jul 28.
2021
ASL Città di Torino

Radin M; Foddai SG; Cecchi I; Roccatello D; Sciascia S;

Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. in Lupus / Lupus. 2021 May;30(6):884-892. doi: 10.1177/0961203321995248. Epub 2021 Feb 16.
2021
ASL Città di Torino

Cecchi I; Radin M; Rubini E; Foddai SG; Barinotti A; Roccatello D; Sciascia S;

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.
2021
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Rossi D; Mengozzi G; Roccatello D; Bazzan M; Giachino O; Baldovino S; Vaccarino A; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Radin M; Sciascia S;

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2021 Jun 16;16(1):280. doi: 10.1186/s13023-021-01906-1.
2021
ASL Città di Torino

Radin M; Foddai SG; Barinotti A; Cecchi I; Rubini E; Sciascia S; Roccatello D;

2021
ASL Città di Torino

Radin M; Foddai S; Cecchi I; Rubini E; Barinotti A; Mahler M; Seaman A; Ramirez C; Casas S; Roccatello D; Sciascia S;

16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. in Lupus / Lupus. 2021 Jul;30(8):1314-1326. doi: 10.1177/09612033211020361. Epub 2021 May 27.
2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Levy RA; Erkan D;

Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players? in European journal of clinical investigation / Eur J Clin Invest. 2021 Feb;51(2):e13441. doi: 10.1111/eci.13441. Epub 2020 Nov 15.
2021
ASL Città di Torino

Mancardi D; Arrigo E; Cozzi M; Cecchi I; Radin M; Fenoglio R; Roccatello D; Sciascia S;

2021
ASL Città di Torino

Radin M; Schreiber K; Cecchi I; Bortoluzzi A; Crisafulli F; de Freitas CM; Bacco B; Rubini E; Foddai SG; Padovan M; Gallo Cassarino S; Franceschini F; Andrade D; Benedetto C; Govoni M; Bertero T; Marozio L; Roccatello D; Andreoli L; Sciascia S;

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.
2021
ASL Città di Torino

Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S;

Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets. in Expert review of clinical immunology / Expert Rev Clin Immunol. 2021 Apr;17(4):395-406. doi: 10.1080/1744666X.2021.1901581. Epub 2021 Mar 3
2021
ASL Città di Torino

Cecchi I; Radin M; Rodríguez-Carrio J; Tambralli A; Knight JS; Sciascia S;

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove. in Frontiers in immunology / Front Immunol. 2021 Jun 16;12:687534. doi: 10.3389/fimmu.2021.687534. eCollection 2021.
2021
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bacco B; Gallo Cassarino S; Roccatello D; Carignola R; Cosseddu D; Norbiato C; Bertero MT; Montaruli B; Bazzan M; Radin M; Sciascia S;

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.
2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Rubini E; Foddai SG; Barinotti A; Vaccarino A; Rossi D; Roccatello D;

Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review. in American journal of nephrology / Am J Nephrol. 2021;52(7):559-571. doi: 10.1159/000517852. Epub 2021 Aug 13.
2021
ASL Città di Torino

Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S;

Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.
2021
ASL Città di Torino

Arbrile M; Radin M; Rossi D; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino

Sciascia S; Aprà F; Baffa A; Baldovino S; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Cinnirella G; Converso M; Cozzi M; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Giusti M; Imperiale D; Imperiale G; Livigni S; Manno E; Massara C; Milone V; Natale G; Navarra M; Oddone V; Osella S; Piccioni P; et alii...